리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 89 Pages
라이선스 & 가격 (부가세 별도)
한글목차
의료용 외골격 세계 시장 규모는 2030년까지 65억 달러에 달할 것으로 예상됩니다
2023년 15억 달러로 추정되는 의료용 외골격 세계 시장은 2023-2030년의 분석 기간 동안 연평균 23.1% 성장하여 2030년에는 65억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 하드웨어는 CAGR 20.2%를 기록하여 분석 기간 말에 32억 달러에 도달할 것으로 예상됩니다. 소프트웨어 분야의 성장률은 분석 기간 동안 26.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 추정됩니다.
미국 시장 4억 3,560만 달러로 추정, 중국은 CAGR 21.2%로 성장 전망
미국의 의료용 외골격 시장은 2023년 4억 3,560만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 연평균 21.2%의 성장률을 보이며 2030년에는 9억 1,410만 달러 규모에 이를 것으로 예측됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 19.6%와 19.1%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 약 13.4%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
세계 의료용 외골격 시장 - 주요 동향 및 촉진요인 요약
의료용 외골격은 헬스케어의 이동성을 어떻게 재정의하고 있는가?
의료용 외골격은 척수 손상에서 회복된 사람이나 다발성 경화증, 뇌졸중과 같은 질병을 앓고 있는 사람 등 거동이 불편한 사람들에게 동력 지원을 제공하는 웨어러블 기기입니다. 이 장치는 사용자의 보행, 기립, 심지어 재활 운동 수행을 도와 삶의 질을 크게 향상시킬 수 있습니다. 의료용 외골격은 회복을 촉진하고 운동 능력을 회복하는 데 사용되는 재활센터와 병원에서 점점 더 많이 사용되고 있습니다. 외골격은 신체적 보조를 강화하여 환자의 자립을 돕고 간병인과 의료 전문가의 부담을 덜어줍니다.
어떤 혁신이 의료용 외골격 시장을 형성하고 있는가?
의료용 외골격의 혁신에는 로봇 공학, 경량 소재, AI 기반 운동 제어 시스템의 발전이 포함됩니다. 이러한 발전은 보다 직관적이고 반응성이 뛰어난 외골격으로 보다 부드럽고 자연스러운 움직임을 가능하게 하고, AI의 통합으로 외골격이 사용자의 움직임을 학습하고 실시간으로 조정할 수 있어 장기적인 재활에 더 효과적일 수 있도록 돕고 있습니다. 또한, 탄소섬유와 첨단 폴리머와 같은 신소재 덕분에 외골격의 무게가 가벼워지고 착용감이 향상되었습니다. 배터리 기술도 개선되어 잦은 충전 없이도 외골격을 장기간 사용할 수 있게 되었습니다.
시장 세분화는 의료용 외골격의 성장을 어떻게 정의하는가?
유형에는 동력식 외골격과 수동식 외골격이 있으며, 동력식 외골격은 더 큰 이동 지원을 제공할 수 있기 때문에 가장 큰 점유율을 차지합니다. 용도는 재활에서 일상 생활 보조 장치까지 다양하지만, 재활은 물리치료에 널리 사용되기 때문에 재활이 주요 부문으로 꼽히고 있습니다. 최종 사용자에는 병원, 재활센터, 재택 요양 기관이 포함되며, 병원과 재활센터가 지배적인 분야입니다. 지리적으로 북미가 시장을 주도하고 유럽이 그 뒤를 잇고 있으며, 아시아태평양은 헬스케어 기술에 대한 투자 증가로 인해 빠르게 성장하고 있습니다.
의료용 외골격 시장의 성장을 가속하는 요인은 무엇인가?
의료용 외골격 시장의 성장은 신경 및 운동 장애의 유병률 증가, 로봇 공학 및 AI의 발전, 재활 기술에 대한 수요 증가 등 여러 가지 요인에 기인합니다. 전 세계 인구의 고령화로 인해 이동 장애 발생률이 증가하면서 외골격과 같은 보조 기술에 대한 수요가 증가하고 있습니다. 로봇 공학 및 동작 제어 시스템의 발전은 이러한 장치를 보다 효과적이고 쉽게 사용할 수 있게 만들어 시장 성장을 더욱 촉진하고 있습니다. 또한, 재활을 통한 환자 예후 개선에 대한 관심이 높아지고 의료용 외골격에 대한 보험 적용 가능성이 높아짐에 따라 시장 확대에 기여하고 있습니다.
조사 대상 기업 예시(총 34건)
Bionik Laboratories Corp
B-TEMIA Inc.
Cyberdyne Inc.
Ekso Bionics Holdings, Inc.
ExoAtlet
Gogoa Mobility Robots SL
Hocoma AG(DIH Technologies의 자회사)
Parker Hannifin Corp
ReWalk Robotics Ltd
Rex Bionics Ltd.
Tyromotion GmbH
US Bionics
Wearable Robotics SRL
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
LSH
영문 목차
영문목차
Global Medical Exoskeleton Market to Reach US$6.5 Billion by 2030
The global market for Medical Exoskeleton estimated at US$1.5 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2023-2030. HardwareComponent, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Software Component segment is estimated at 26.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$435.6 Million While China is Forecast to Grow at 21.2% CAGR
The Medical Exoskeleton market in the U.S. is estimated at US$435.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$914.1 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.6% and 19.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.
Global Medical Exoskeleton Market - Key Trends and Drivers Summarized
How Are Medical Exoskeletons Redefining Mobility in Healthcare?
Medical exoskeletons are wearable devices that provide powered support to individuals with mobility impairments, such as those recovering from spinal cord injuries or suffering from conditions like multiple sclerosis or stroke. These devices assist users in walking, standing, and even performing rehabilitation exercises, greatly improving their quality of life. Medical exoskeletons are increasingly being adopted in rehabilitation centers and hospitals, where they are used to accelerate recovery and restore mobility. By offering enhanced physical assistance, exoskeletons are also enabling patients to achieve greater independence, reducing the burden on caregivers and healthcare professionals.
What Innovations Are Shaping the Medical Exoskeleton Market?
Innovations in medical exoskeletons include advancements in robotics, lightweight materials, and AI-driven motion control systems. These developments are enabling more intuitive and responsive exoskeletons, allowing for smoother and more natural movements. The integration of AI is helping exoskeletons learn from user movements and adjust in real-time, making them more effective for long-term rehabilitation. Additionally, exoskeletons are becoming lighter and more comfortable to wear, thanks to new materials such as carbon fiber and advanced polymers. Battery technology is also improving, allowing exoskeletons to be used for longer periods without the need for frequent recharging.
How Do Market Segments Define the Growth of Medical Exoskeletons?
Types include powered and passive exoskeletons, with powered exoskeletons accounting for the largest share due to their ability to provide greater mobility assistance. Applications range from rehabilitation to assistive devices for daily use, with rehabilitation being the primary segment as these devices are widely used in physical therapy. End-users include hospitals, rehabilitation centers, and home care settings, with hospitals and rehabilitation centers being the dominant sectors. Geographically, North America leads the market, followed by Europe, while Asia-Pacific is seeing rapid growth due to increasing investments in healthcare technology.
What Factors Are Driving the Growth in the Medical Exoskeleton Market?
The growth in the medical exoskeleton market is driven by several factors, including the increasing prevalence of neurological and mobility disorders, advancements in robotics and AI, and rising demand for rehabilitation technologies. As the global population ages, the incidence of mobility impairments is rising, driving demand for assistive technologies like exoskeletons. Advances in robotics and motion control systems are making these devices more effective and accessible, further boosting market growth. Additionally, the growing focus on improving patient outcomes through rehabilitation and the increasing availability of insurance coverage for medical exoskeletons are contributing to the market's expansion.
Select Competitors (Total 34 Featured) -
Bionik Laboratories Corp
B-TEMIA Inc.
Cyberdyne Inc.
Ekso Bionics Holdings, Inc.
ExoAtlet
Gogoa Mobility Robots SL
Hocoma AG (A Subsidiary of DIH Technologies)
Parker Hannifin Corp
ReWalk Robotics Ltd
Rex Bionics Ltd.
Tyromotion GmbH
US Bionics
Wearable Robotics SRL
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Medical Exoskeleton - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Rehabilitation and Mobility Assistance Drives Growth in Medical Exoskeleton Market
Technological Advancements in Wearable Exoskeletons Strengthen Business Case for Adoption
Growing Focus on Improving Mobility in Patients with Disabilities Expands Addressable Market for Exoskeletons
Expansion of Medical Exoskeletons in Physical Therapy and Neurological Rehabilitation Fuels Market Growth
Increasing Adoption of Powered Exoskeletons for Spinal Cord Injury Patients Expands Market Opportunities
Technological Innovations in Lightweight and Battery-Powered Exoskeletons Propel Market Expansion
Rising Focus on Enhancing Patient Independence and Quality of Life Drives Demand for Medical Exoskeletons
Growing Use of Medical Exoskeletons in Stroke Recovery and Gait Training Expands Market Potential
Focus on Reducing Rehabilitation Time and Improving Therapy Outcomes Strengthens Demand for Exoskeletons
Rising Adoption of Medical Exoskeletons in Elderly Care and Assisted Living Facilities Expands Addressable Market
Technological Advancements in AI-Enabled and Smart Exoskeleton Systems Propel Market Growth
Rising Demand for Pediatric Exoskeletons for Mobility Assistance Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 3: World 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 6: World 18-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 9: World 18-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 12: World 18-Year Perspective for Powered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 15: World 18-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 18: World 18-Year Perspective for Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 21: World 18-Year Perspective for Stationary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2024 & 2030
TABLE 22: World Medical Exoskeleton Market Analysis of Annual Sales in US$ for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 25: USA 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 28: USA 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 31: USA 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 34: Canada 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 37: Canada 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 40: Canada 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
JAPAN
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 43: Japan 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 46: Japan 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 49: Japan 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
CHINA
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 52: China 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 53: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 55: China 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 58: China 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
EUROPE
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 61: Europe 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 64: Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 67: Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 70: Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
FRANCE
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 71: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 73: France 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 74: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 75: France Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 76: France 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 77: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 79: France 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
GERMANY
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 82: Germany 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 83: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 84: Germany Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 85: Germany 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 88: Germany 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
ITALY
TABLE 89: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 90: Italy Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 91: Italy 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 92: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 93: Italy Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 94: Italy 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 97: Italy 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
UNITED KINGDOM
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 98: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 99: UK Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 100: UK 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 101: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 102: UK Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 103: UK 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 104: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 106: UK 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
REST OF EUROPE
TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 109: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 111: Rest of Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 112: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 114: Rest of Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 115: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
ASIA-PACIFIC
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 117: Asia-Pacific Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 118: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 120: Asia-Pacific Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 121: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 123: Asia-Pacific Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 124: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030
REST OF WORLD
TABLE 125: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of World Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 127: Rest of World 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2024 & 2030
TABLE 128: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of World Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 130: Rest of World 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2024 & 2030
TABLE 131: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of World Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2022 and % CAGR
TABLE 133: Rest of World 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2024 & 2030